Cita APA (7a ed.)
Kim, H., Lee, J., Chung, M., Park, S. H., Park, J. H., Choi, H., & Hwang, J. (2022). Tamarixetin Abrogates Adipogenesis Through Inhibiting p300/CBP-Associated Factor Acetyltransferase Activity in 3T3-L1 Preadipocyte Cells. Journal of Medicinal Food, 25(3), 272-281.
Cita Chicago Style (17a ed.)
Kim, Hyo-Jin, Jangho Lee, Min-Yu Chung, Soo Hyun Park, Jae Ho Park, Hyo-Kyoung Choi, y Jin-Taek Hwang. "Tamarixetin Abrogates Adipogenesis Through Inhibiting P300/CBP-Associated Factor Acetyltransferase Activity in 3T3-L1 Preadipocyte Cells." Journal of Medicinal Food 25, no. 3 (2022): 272-281.
Cita MLA (9a ed.)
Kim, Hyo-Jin, et al. "Tamarixetin Abrogates Adipogenesis Through Inhibiting P300/CBP-Associated Factor Acetyltransferase Activity in 3T3-L1 Preadipocyte Cells." Journal of Medicinal Food, vol. 25, no. 3, 2022, pp. 272-281.
Precaución: Estas citas no son 100% exactas.